Human engineered heart tissue: analysis of contractile force

Autor/innen

  • I. Mannhardt
  • K. Breckwoldt
  • D. Letuffe-Brenière
  • S. Schaaf
  • H. Schulz
  • C. Neuber
  • A. Benzin
  • T. Werner
  • A. Eder
  • T. Schulze
  • B. Klampe
  • T. Christ
  • M.N. Hirt
  • N. Huebner
  • A. Moretti
  • T. Eschenhagen
  • A. Hansen

Journal

  • Stem Cell Reports

Quellenangabe

  • Stem Cell Rep 7 (1): 29-42

Zusammenfassung

  • Analyzing contractile force, the most important and best understood function of cardiomyocytes in vivo is not established in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). This study describes the generation of 3D, strip-format, force-generating engineered heart tissues (EHT) from hiPSC-CM and their physiological and pharmacological properties. CM were differentiated from hiPSC by a growth factor-based three-stage protocol. EHTs were generated and analyzed histologically and functionally. HiPSC-CM in EHTs showed well-developed sarcomeric organization and alignment, and frequent mitochondria. Systematic contractility analysis (26 concentration-response curves) reveals that EHTs replicated canonical response to physiological and pharmacological regulators of inotropy, membrane- and calcium-clock mediators of pacemaking, modulators of ion-channel currents, and proarrhythmic compounds with unprecedented precision. The analysis demonstrates a high degree of similarity between hiPSC-CM in EHT format and native human heart tissue, indicating that human EHTs are useful for preclinical drug testing and disease modeling.


DOI

doi:10.1016/j.stemcr.2016.04.011